This inventor holds 7 USPTO granted patents and 4 published patent applications and 7 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc.. Active years: 2008-2021.
Location History:
- South Brunswick, NJ (US) (2017 - 2018)
- Dayton, NJ (US) (2008 - 2021)
Company Filing History:
Years Active: 2008-2021
Title: Jiafang He: Innovator in Pharmaceutical Chemistry
Introduction
Jiafang He is a prominent inventor based in Dayton, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of 7 patents, he has made remarkable advancements in the development of therapeutic agents.
Latest Patents
His latest patents include "Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors." This invention focuses on pyrazolopyrimidine compounds that may serve as therapeutic agents for treating disorders associated with phosphodiesterase 9 (PDE9). These compounds are particularly relevant for addressing cardiovascular and cerebrovascular diseases, such as hypertension and heart failure, as well as neurological disorders like schizophrenia and Huntington's disease. Another notable patent is for "Factor XIa inhibitors," which provides a compound and pharmaceutical compositions aimed at treating or preventing thromboses and related conditions. These compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.
Career Highlights
Throughout his career, Jiafang He has worked with leading pharmaceutical companies, including Merck Sharp & Dohme Corp. and Merck & Co., Inc. His work has significantly impacted the field of drug development, particularly in creating innovative solutions for complex health issues.
Collaborations
Jiafang He has collaborated with notable professionals in his field, including Weiguo Liu and Scott D Edmondson. These collaborations have further enhanced his research and development efforts.
Conclusion
Jiafang He is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic agents. His contributions continue to influence the medical field and improve patient outcomes.